Is your organization missing from this list? Reach out to Noelle Stango and Marissa Fiorentino to learn more about the complimentary strategic partnership program: nstango@mjhlifesciences.com and mfiorentino@mjhlifesciences.com
Biopsy grade alone may underestimate risk in GG1 prostate cancer
FDA updates in urology: July 2025
SunRISe-1 data of TAR-200 in NMIBC published in Journal of Clinical Oncology
Preclinical data show promise of ATNM-400 for prostate cancer